All Type of News
One in 3 pharmacists to envision unclear future.
One in 3 pharmacists admitted it positive for the post notification system over the substituted dispensing while most of medical doctors also did not show any bad impression about the post notification. 1 in 3 pharmac...
Government mulls big deal with U.S.
The government affirmed its position to seek a big deal with the united States in its attempt to establish a free trade agreement (FTA) during the seventh round of talks scheduled for Washington, D.C. on February 11 t...
KPTA targets $1.4 billion as this year's pharmaceutical export
The Korea Pharmaceutical Traders Associations is continuing its export drive this year.
The KPTA said on February 8 that last year's pharmaceutical export amounted to $1.2 billion and set up this year's export targ...
KPMA protests Korean government's trade-off with US
The Korea Pharmaceutical Manufacturers Association (KPMA) opposed the government's plan for the Korea-U.S. free trade agreement (FTA) that Korea could compromise with the U.S. by giving wider access to Korea's auto an...
Post notification of substituted dispensing to be simplified.
The post notification of any substituted dispensing to the prescribed doctors was a stumbling block for the substituted dispensing activities, but in the future the post notification process seems to be far simplified...
3 drugs including simvastatin to test its bio equivalency.
Earlier the KMA raised questions about the bio equivalency tests of simvastatin preparations and other 2 products, for which the KFDA decided to take retests only.
The bio equivalency tests for 3 drugs including si...
Pharmaceutical growth seen slowing in first quarter
Leading pharmaceutical firms' growth in sales is expected to slow further in the first quarter of this year on sluggish domestic demand for prescription drugs, pharmaceutical business sources said.
The downturn of ...
Initial clinical study terms to shorten by 1 to 2 years.
The initial clinical study terms for anti-cancer drugs seems to be shortened by one to two years.
The KFDA announced "Optimizing plan for non-clinical test data in the clinical study of anti-cancer drug" on Feb...
More than 4,000 products to delete from NHI reimbursement schedule.
Under the positive list system exercise, it is estimated for about 4,000 drugs with no records of production nor billing during the past 2 years to be deleted from the NHI reimbursement schedule.
However, the delet...
3,462 incentive drugs available for substitute dispensing
A total of 3,462 incentive drugs, which were endorsed by bioequivalence tests, are available for substitute dispensing at the end of January this year, according to the Health Insurance Review Agency.
The Health au...
